BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19682812)

  • 1. [Gastroduodenal ulcer before and after Helicobacter pylori].
    Bommelaer G; Stef A
    Gastroenterol Clin Biol; 2009; 33(8-9):626-34. PubMed ID: 19682812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Helicobacter pylori with gastroduodenal diseases.
    Hirai Y; Hayashi S; Shimomura H; Oguma K; Yokota K
    Jpn J Infect Dis; 1999 Oct; 52(5):183-97. PubMed ID: 10680084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Helicobacter pylori in peptic ulcer disease.
    O'Connor HJ
    Scand J Gastroenterol Suppl; 1994; 201():11-5. PubMed ID: 8047817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori: beyond peptic ulcer disease.
    Wisniewski RM; Peura DA
    Gastroenterologist; 1997 Dec; 5(4):295-305. PubMed ID: 9436005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Helicobacter pylori in gastroduodenal disease.
    Wang KK
    Compr Ther; 1991 Sep; 17(9):35-8. PubMed ID: 1769198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori and the pathogenesis of gastroduodenal disease: Implications for the management of peptic ulcer disease.
    Rotimt O; Nduduba DA; Otegbeye FM
    Niger Postgrad Med J; 2005 Dec; 12(4):289-98. PubMed ID: 16380742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peptic ulcer and Helicobacter pylori, diagnosis and therapy].
    Fixa B; Komárková O
    Cas Lek Cesk; 1999 Jun; 138(12):355-8. PubMed ID: 10566201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma.
    Graham DY
    Prev Med; 1994 Sep; 23(5):712-6. PubMed ID: 7845945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
    Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
    Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Helicobacter pylori infections.
    Thijs JC; Kuipers EJ; van Zwet AA; Pena AS; de Graaff J
    QJM; 1995 Jun; 88(6):369-89. PubMed ID: 7648229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation.
    Konturek SJ; Konturek PC; Konturek JW; Plonka M; Czesnikiewicz-Guzik M; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():29-50. PubMed ID: 17033104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
    Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
    Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The attitude of primary health care physicians in the metropolitan area of Barcelona about the diagnosis and treatment of Helicobacter pylori infection in gastroduodenal diseases].
    Martínez-Sánchez G; Saperas E; Benavent J; Mearin F; Piñol JL; Barenys M; Mascort JJ; Forné M; Bordas JM; Azagra R; Piqué JM
    Gastroenterol Hepatol; 1998 Dec; 21(10):473-8. PubMed ID: 9927791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F; De Luca L; Graham DY
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common-sense management of Helicobacter pylori-associated gastroduodenal disease. Personal views.
    Sloane R; Cohen H
    Gastroenterol Clin North Am; 1993 Mar; 22(1):199-206. PubMed ID: 8449567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.